Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CRIZOTINIB vs CUPRIC ANHYDROUS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CRIZOTINIB vs CUPRIC ANHYDROUS: Safety Overview

Metric CRIZOTINIB CUPRIC ANHYDROUS
Total FAERS Reports 9,948 110
Deaths Reported 3,173 32
Death Rate 31.9% 29.1%
Hospitalizations 2,520 58
Average Patient Age 58.5 yrs 57.2 yrs
% Female Patients 55.2% 23.2%
FDA Approval Date Aug 26, 2011 N/A
Manufacturer Pfizer Laboratories Div Pfizer Inc Hahnemann Laboratories, INC.
Route ORAL ORAL
Marketing Status Prescription N/A